CRBG Stock Analysis: Corebridge Financial | NYSE
Asset Management | NYSE, USA | Market Cap: 15.375m USD | 12M Return: 3.6% | US21871X1090 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 139M
EPS Trend: -55.2%
Qual. Beats: 0
Rev. Trend: 43.4%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
Seasonality 3.9 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Corebridge Financial, Inc. (NYSE: CRBG) is a U.S.-based provider of retirement solutions and insurance products, headquartered in Houston, Texas and incorporated in 1998. The company was formerly known as SAFG Retirement Services, Inc., and it operates through four business segments: Individual Retirement, Group Retirement, Life Insurance, and Institutional Markets.
Its Individual Retirement segment offers fixed, fixed index, registered index-linked, and variable annuities, while the Group Retirement segment provides in-plan and out-of-plan products including recordkeeping platforms, group annuities, investment advisory, and brokerage services. The Life Insurance segment distributes term, whole, index universal, and guaranteed universal life insurance, and the Institutional Markets segment supplies stable value wraps, structured settlement and pension risk transfer annuities, corporate and bank-owned life insurance, and guaranteed investment contracts.
Corebridge operates within the diversified financial services subsector of the financials industry, with annuities serving as its core retirement product line. Annuities are insurance contracts that convert premiums into a stream of guaranteed income, commonly used to manage longevity risk in retirement planning. The company was spun off from American International Group (AIG) and completed its initial public offering on September 15, 2022.
- Pension risk transfer premiums accelerate Institutional Markets growth
- Interest rate moves pressure fixed annuity spreads and hedging costs
- Share buybacks accelerate capital return to shareholders
| Net Income: 907.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.00 > 0.02 and ΔFCF/TA 0.03 > 1.0 |
| NWC/Revenue: -90.91% < 20% (prev 2.23k%; Δ -2.33k% < -1%) |
| CFO/TA 0.00 > 3% & CFO 1.85b > Net Income 907.0m |
| Net Debt (5.93b) to EBITDA (2.39b): 2.48 < 3 |
| Current Ratio: 0.09 > 1.5 & < 3 |
| Outstanding Shares: last quarter (454.2m) vs 12m ago -17.46% < -2% |
| Gross Margin: 94.13% > 18% (prev 80.28%; Δ 13.85% > 0.5%) |
| Asset Turnover: 2.31% > 50% (prev 0.72%; Δ 1.59% > 0%) |
| Interest Coverage Ratio: 3.04 > 6 (EBIT TTM 1.61b / Interest Expense TTM 529.0m) |
| A: -0.02 (Total Current Assets 817.0m - Total Current Liabilities 9.36b) / Total Assets 416b |
| B: 0.04 (Retained Earnings 18.1b / Total Assets 416b) |
| C: 0.00 (EBIT TTM 1.61b / Avg Total Assets 407b) |
| D: 0.03 (Book Value of Equity 10.7b / Total Liabilities 404b) |
| Altman-Z'' = 0.06 = B |
As of August 12, 2026, the stock is trading at USD 33.39 with a total of 12,110,667 shares traded. Over the past week, the price has changed by +5.66%, over one month by +8.34%, over three months by +27.85% and over the past year by +3.62%.
Current recommended Stop Loss: 32.00 (which is 4.2% or 1.4 ATR below the current price).
Corebridge Financial has received a consensus analysts rating of 4.07. Therefore, it is recommended to buy CRBG.
- StrongBuy: 6
- Buy: 5
- Hold: 2
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 38.2 | 14.3% |
P/E Trailing = 21.5563
P/E Forward = 4.6253
P/S = 0.7878
P/B = 1.478
Revenue TTM = 9.40b USD
EBIT TTM = 1.61b USD
EBITDA TTM = 2.39b USD
Long Term Debt = 9.62b USD (from longTermDebt, last quarter)
Short Term Debt = 1.25b USD (from shortTermDebt, last quarter)
Debt = 10.9b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.93b USD (calculated: Debt 10.9b - CCE 4.94b)
Enterprise Value = 21.3b USD (15.4b + Debt 10.9b - CCE 4.94b)
Interest Coverage Ratio = 3.04 (Ebit TTM 1.61b / Interest Expense TTM 529.0m)
EV/FCF = 11.50x (Enterprise Value 21.3b / FCF TTM 1.85b)
FCF Yield = 8.69% (FCF TTM 1.85b / Enterprise Value 21.3b)
FCF Margin = 19.70% (FCF TTM 1.85b / Revenue TTM 9.40b)
Net Margin = 9.65% (Net Income TTM 907.0m / Revenue TTM 9.40b)
Gross Margin = 94.13% ((Revenue TTM 9.40b - Cost of Revenue TTM 552.0m) / Revenue TTM)
Gross Margin QoQ = none% (prev 75.70%)
Tobins Q-Ratio = 0.05 (Enterprise Value 21.3b / Total Assets 416b)
Interest Expense / Debt = 4.87% (Interest Expense 529.0m / Debt 10.9b)
Taxrate = 18.74% (202.0m / 1.08b)
NOPAT = 1.31b (EBIT 1.61b * (1 - 18.74%))
Current Ratio = 0.09 (Total Current Assets 817.0m / Total Current Liabilities 9.36b)
Debt / Equity = 1.02 (Debt 10.9b / totalStockholderEquity, last quarter 10.7b)
Debt / EBITDA = 2.48 (Net Debt 5.93b / EBITDA 2.39b)
Debt / FCF = 3.20 (Net Debt 5.93b / FCF TTM 1.85b)
Total Stockholder Equity = 12.0b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.22% (Net Income 907.0m / Total Assets 416b)
RoE = 7.53% (Net Income TTM 907.0m / Total Stockholder Equity 12.0b)
RoCE = 7.42% (EBIT 1.61b / Capital Employed (Equity 12.0b + L.T.Debt 9.62b))
RoIC = 0.32% (NOPAT 1.31b / Invested Capital 407b)
WACC = 7.29% (E(15.4b)/V(26.2b) * Re(9.65%) + D(10.9b)/V(26.2b) * Rd(4.87%) * (1-Tc(0.19)))
Discount Rate = 9.65% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -98.27 | Cagr: -13.22%
[DCF] Terminal Value 76.70% ; FCFF base≈1.78b ; Y1≈1.94b ; Y5≈2.43b
[DCF] Fair Price = 69.96 (EV 37.1b - Net Debt 5.93b = Equity 31.2b / Shares 445.8m; r=8.35% [WACC [floored]]; 5y FCF grow 10.37% → 2.50% )
EPS Correlation: -55.19 | EPS CAGR: -19.22% | SUE: 0.05 | # QB: 0
Revenue Correlation: 43.38 | Revenue CAGR: 24.92% | SUE: -0.11 | # QB: 0
EPS current Quarter (2026-09-30): EPS=1.19 | Chg30d=-5.29% | Revisions=-42% | Analysts=9
EPS current Year (2026-12-31): EPS=4.47 | Chg30d=-3.89% | Revisions=-80% | GrowthEPS=+1.1% | GrowthRev=-2.5%
EPS next Year (2027-12-31): EPS=5.76 | Chg30d=-1.22% | Revisions=-36% | GrowthEPS=+28.8% | GrowthRev=+9.5%
[Analyst] Revisions Ratio: -66% (up=4, down=25)